Profile
ABOS NVO VRTX REGN SGEN ARGX
Company Name Acumen Pharmaceuticals, Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $113.55M $292.61B $105.75B $77.45B $43.15B $38.15B
Employees 0.05K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Mr. Daniel J. O'Connell M.B.A. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ABOS NVO VRTX REGN SGEN ARGX
Quant Rating Score 2 3 3 4 3 1
Quant Rating Sell Neutral Neutral Buy Neutral Strong Sell
Trading
ABOS NVO VRTX REGN SGEN ARGX
Last Close $1.89 $87.65 $410.65 $716.68 $228.74 $632.04
High 52 $4.64 $146.91 $516.74 $1201.76 $228.74 $638.33
Low 52 $1.77 $85 $392.81 $701.85 $228.74 $356.01
Price vs. 52 Week High -59.27 % -40.34 % -20.53 % -40.36 % 0 % -0.99 %
Price vs. 52 Week Low 6.78 % 3.12 % 4.54 % 2.11 % 0 % 77.53 %
Total Return
ABOS NVO VRTX REGN SGEN ARGX
1 Month Return -16.37 % -17.41 % -11.6 % -5.06 % 0 % 2.84 %
3 Month Return -23.79 % -27.42 % -11.28 % -31.27 % 0 % 17.89 %
6 Month Return -19.92 % -39.34 % -13.09 % -31.8 % 0 % 42.05 %
9 Month Return -53.9 % -31.55 % -1.6 % -25.83 % 0 % 58.57 %
YTD Return -50.78 % -15.27 % 0.92 % -18.4 % 0 % 66.14 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABOS NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) - 1.54 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -2243.8 % 1.25 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) - 9.9 % - - - -
Payout Ratio (TTM) - 46.6 % - - - -
Growth
ABOS NVO VRTX REGN SGEN ARGX
Asset Growth 57.75 % 30.35 % 25.23 % 13.23 % -1.21 % 44.93 %
Gross Profit Growth -24940.24 % 32.32 % 9.64 % 6.49 % 22.93 % 190.7 %
Revenue Growth - 31.26 % 10.51 % 7.76 % 24.65 % 198.56 %
Revenue 3 Year -100 % 90.03 % 60.36 % 55.67 % 91.56 % 2071.96 %
Revenue 5 Year -100 % 123.63 % 219.55 % 110.3 % 215.48 % 3041.46 %
Revenue 10 Year -100 % 65.69 % 610.45 % 549.62 % 494.04 % 9009.53 %
EBIT Growth -35.15 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Net Income Growth -29.39 % 50.71 % 8.96 % -8.87 % 9.51 % 58.42 %
Net Income 3 Yeari Growth Per Share -492.09 % 106.26 % 34.59 % 13.48 % -763.59 % 64.01 %
Net Income 5 Yeari Growth Per Share -451.57 % 133.27 % 70.33 % 74.02 % -276.93 % -143.65 %
Net Income 10 Yeari Growth Per Share -451.57 % 98.1 % 809.6 % 871.12 % -624.16 % -857 %
Operating Income Growth -35.15 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Operating Cash Flow Growth (CFG) -22.5 % 38.06 % -14.35 % -8.39 % 9.07 % 51.28 %
Operating 3 Year CFG -378.63 % 117.73 % 9.63 % 76.95 % -147.99 % 21.71 %
Operating 5 Year CFG -423 % 162.84 % 174.78 % 125.17 % -195.86 % -329.63 %
Operating 10 Year CFG -423 % 150.28 % 6084.35 % 713.56 % -2622.09 % -1280.2 %
EPS Growth -8 % 51.88 % 8.33 % -8.54 % 10.81 % 60.46 %
EPS Diluted Growth -8 % 52.37 % 8.35 % -9.03 % 10.81 % 60.46 %
Book Value Per Share 18.42 % 28.67 % 25.58 % 15.03 % -9.83 % 38.53 %
Share Holder 3 Year Equity Growth Per Share 1289.07 % 74.77 % 104.06 % 137.56 % 33.72 % 93.75 %
Share Holder 5 Year Equity Growth Per Share 2035.73 % 121.34 % 291.14 % 219.1 % 220.81 % 318.81 %
Share Holder 10 Year Equity Growth Per Share 2035.73 % 49.24 % 1030.79 % 1286.9 % 691.19 % 3654.06 %
Dividend Per Share Growth - 26.56 % - - - -
Dividend 3 Year Growth Per Share - 63.98 % - - - -
Dividend 5 Year Growth Per Share - 79.57 % - - - -
Dividend 10 Year Growth Per Share - 94.94 % - - - -
Debt Growth 27030.48 % 4.74 % 44.1 % 0.06 % -23.28 % 60.95 %
Free Cash Flow Growth -22.01 % 9.17 % -16.47 % -17.11 % 3.67 % 51.98 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
ABOS NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM 55.86 % 84.66 % 86.1 % 84.42 % 72.37 % 86.82 %
Return on Assets TTM -30.59 % 23.83 % -2.16 % 12.43 % -11.76 % -2.13 %
Return on Equity TTM -32.99 % 86.4 % -2.88 % 16.85 % -16.53 % -2.75 %
Return on Capital Employed TTM -37.6 % 62.74 % -1.72 % 11.85 % -16.87 % -8.98 %
Net Income Per EBT TTM 100 % 79.43 % -184.82 % 93.66 % 100.55 % 167.72 %
EBT Per Ebit TTM 87.91 % 100.52 % -82.68 % 124.1 % 94.01 % 15.76 %
EBIT Per Revenue TTM -32036.55 % 43.84 % -2.96 % 28.92 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM -225.86 % 207.5 % - 214.08 % -185.98 % -
Receivables Turnover TTM - 3.89 6.06 2.27 1.98 3.45
Payables Turnover TTM 0.05 1.72 3.73 4.34 1.54 1.06
Inventory Turnover TTM - 1.09 1.37 0.71 0.65 0.91
Fixed Asset Turnover TTM 75.32 % 225.8 % 422.11 % 311.93 % 256.83 % 6116.64 %
Asset Turnover TTM 0.11 % 68.08 % 47.71 % 36.98 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM -1.12 26.54 -3.27 39.29 -1.12 -2.42
Free Cash Flow Per Share TTM -1.12 15.14 -4.51 31.25 -1.62 -3.52
Cash Per Share TTM 333.46 % 1681.33 % 2528.88 % 9062.44 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM -23211.72 % 43.69 % -7.94 % 30.67 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.04 % 57.03 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM -225.86 % 207.5 % - 214.08 % -185.98 % -
Price To Free Cash Flows Ratio TTM -1.69 42.16 -90.87 22.93 -141.85 -180.64
Price To Operating Cash Flows Ratio TTM -1.69 24.15 -125.74 18.24 -203.89 -260.94
Price Cash Flow Ratio TTM -1.69 24.15 -125.74 18.24 -203.89 -260.94
Income Statement (TTM)
ABOS NVO VRTX REGN SGEN ARGX
Revenue $0B $232.26B $9.87B $13.12B $1.96B $1.23B
Gross Profit $-0.04B $196.5B $8.61B $11.3B $1.55B $1.11B
Gross Profit Ratio 0% 84.6% 87.21% 86.16% 79.1% 90.39%
EBITDA $-0.05B $114.63B $4.61B $4.69B $-0.62B $-0.22B
Net Income $-0.05B $83.68B $3.62B $3.95B $-0.61B $-0.3B
EPS Diluted -1.08 18.62 13.89 34.77 -3.3 -5.16
Balance Sheet (MRQ)
ABOS NVO VRTX REGN SGEN ARGX
Long Term Debt $0.03B $20.53B $1.45B $2.7B $0.04B $0.02B
Total Liabilities $0.04B $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $0.27B $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $0.24B $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $0.03B $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $0.31B $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
ABOS NVO VRTX REGN SGEN ARGX
Net Income $-0.05B $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.04B $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 3.2435
ABCL AbCellera Biologics Inc. 2.95
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.66
ABIO ARCA biopharma, Inc. 28.8
ABPWW 0.18
ABSI Absci Corporation 2.785
ABUS Arbutus Biopharma Corporation 3.205
ABVC ABVC BioPharma, Inc. 0.6022
ABVX Abivax SA American Depositary Shares 7.2
ACAD ACADIA Pharmaceuticals Inc. 16.97
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.9188
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.13
ACHV Achieve Life Sciences, Inc. 3.66
ACIU AC Immune SA 2.805
ACLX Arcellx, Inc. 78.72
ACRV Acrivon Therapeutics, Inc. Common Stock 5.92
ACST Acasti Pharma Inc. 3.37
ETFs With Exposure to ABOS
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00259 221.82
VTI Vanguard Total Stock Market Index Fund 0 293.62
IBB iShares Biotechnology ETF 0.01258 133.526
IWN iShares Russell 2000 Value ETF 0.00554 164.12
BIB ProShares Ultra Nasdaq Biotechnology 0.00535472 51.54
VXF Vanguard Extended Market Index Fund 0 191.701
HDG ProShares Hedge Replication ETF 0.000411371 49.4103
UWM ProShares Ultra Russell2000 0.00113748 42.29
VTHR Vanguard Russell 3000 Index Fund 0 262.89
IWC iShares Micro-Cap ETF 0.01808 130.825
URTY ProShares UltraPro Russell2000 0.000524907 49.95
VTWV Vanguard Russell 2000 Value Index Fund 0.01 144.61
CSML IQ Chaikin U.S. Small Cap ETF 0.17 34.9484
VTWO Vanguard Russell 2000 Index Fund 0 89.74
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 103.39
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 103.37
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 50.85
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 50.84
VBINX Vanguard Balanced Index Fund Investor Shares 0 50.84
BMED BlackRock Future Health ETF 0.03 25.4149
DFAU Dimensional US Core Equity Market ETF 0.00048189 40.9975
IBBQ Invesco Nasdaq Biotechnology ETF 0.017 21.6761
DFAT Dimensional U.S. Targeted Value ETF 0.00026286 55.5301
DFAS Dimensional U.S. Small Cap ETF 0.00031635 65.29
DFAC Dimensional U.S. Core Equity 2 ETF 0.00002324 34.9288
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.03546 6.074
VTSAX Vanguard Total Stock Market Index Fund 0 144.71
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01585 6.319
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 147.65
VITSX Vanguard Total Stock Market Index Fund 0 144.73
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.01585 6.321
IBRN iShares Neuroscience and Healthcare ETF 0.17376 26.12
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000123949 101.68
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 147.66
AVSC Avantis U.S. Small Cap Equity ETF 0.01 54.33
DCOR Dimensional ETF Trust 0.00005219 64.82
VEMPX Vanguard Extended Market Index InstlPlus 0 364.38
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 271.49
RSSL Global X Funds 0 88.38
DXUV Dimensional ETF Trust 0.0000186 53.21
Unlock